Compare · HPCO vs KRBP

HPCO vs KRBP

Side-by-side comparison of Hempacco Co. Inc. (HPCO) and Kiromic BioPharma Inc. (KRBP): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HPCO and KRBP operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
MetricHPCOKRBP
Company
Hempacco Co. Inc.
Kiromic BioPharma Inc.
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NASDAQ
IPO
2022
2020
News (4w)
0
0
Recent ratings
0
0
KRBP

Kiromic BioPharma Inc.

Kiromic BioPharma, Inc., a target discovery and gene editing company, focuses on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1; and chimeric gamma delta PD1 T cell switch receptor therapy. It has license agreements with Mercer University; CGA 369 Intellectual Holdings, Inc.; and Longwood University, as well as research and development collaboration agreements with Molipharma, S.R.L. and Leon Office (H.K.). The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

Latest HPCO

Latest KRBP